BioCryst Pharmaceuticals BCRX
$ 7.24
-1.9%
Quarterly report 2024-Q3
added 11-05-2024
BioCryst Pharmaceuticals Financial Statements 2011-2024 | BCRX
Annual Financial Statements BioCryst Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.12 B | 1.68 B | 2.98 B | 1.8 B | 324 M | 899 M | 385 M | 445 M | 508 M | 680 M | 573 M | 78.2 M | 158 M |
Shares |
192 M | 186 M | 179 M | 167 M | 116 M | 103 M | 84.5 M | 73.7 M | 72.9 M | 66.8 M | 55.2 M | 49.5 M | 45.1 M |
Historical Prices |
5.85 | 9.04 | 16.6 | 10.8 | 3 | 8.26 | 4.97 | 6.24 | 1.99 | 10.2 | 11.7 | 1.2 | 4.66 |
Net Income |
-227 M | -247 M | -184 M | -183 M | -109 M | -101 M | -65.8 M | -55.1 M | -43 M | -45.2 M | -30.1 M | -39.1 M | -56.9 M |
Revenue |
331 M | 271 M | 157 M | 17.8 M | 48.8 M | 20.7 M | 25.2 M | 26.4 M | 48.3 M | 13.6 M | 17.3 M | 26.3 M | 19.6 M |
Cost of Revenue |
4.48 M | 6.41 M | 7.23 M | 1.55 M | 3.73 M | - | 1.14 M | 2.3 M | - | - | - | - | - |
Gross Profit |
- | - | - | - | 44.7 M | 20.2 M | 23.5 M | 23.7 M | 46.4 M | 13.5 M | 17.2 M | 26.2 M | 19.6 M |
Operating Income |
-104 M | -148 M | -178 M | -175 M | -99.5 M | -94.2 M | -57.4 M | -48.6 M | -39.4 M | -45.8 M | -30.7 M | -33.9 M | -49.6 M |
Interest Expense |
108 M | 99.1 M | 59.3 M | 14.5 M | 11.9 M | 9.18 M | 8.56 M | 6.49 M | 5.2 M | 5 M | 4.78 M | 4.67 M | 3.77 M |
EBITDA |
-102 M | -147 M | -177 M | -174 M | -98.7 M | -93.4 M | -56.7 M | -48.1 M | -39.3 M | -45.6 M | -30.4 M | -31.5 M | -48.7 M |
Operating Expenses |
- | - | - | - | 144 M | 114 M | 80.9 M | 72.3 M | 85.8 M | 59.3 M | 48 M | 58.3 M | 69.2 M |
General and Administrative Expenses |
214 M | 159 M | 119 M | 67.9 M | 37.1 M | 29.5 M | 13.9 M | 11.3 M | 13 M | 7.46 M | 5.22 M | 6.83 M | 12.3 M |
All numbers in USD currency
Quarterly Income Statement BioCryst Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
207 M | 206 M | 206 M | 206 M | 190 M | 189 M | 189 M | 188 M | 186 M | 186 M | 185 M | 184 M | 179 M | 179 M | 178 M | 177 M | 177 M | 177 M | 177 M | 154 M | 154 M | 154 M | 154 M | 110 M | 110 M | 110 M | 110 M | 98.4 M | 98.4 M | 98.4 M | 98.4 M | 73.8 M | 73.8 M | 73.7 M | 73.8 M | 73.4 M | 73.4 M | 72.6 M | 72.3 M | 72 M | 72 M | 63.6 M | 59.6 M | 59.1 M | 59.1 M | 59.1 M | 59.1 M | 50.9 M | 50.9 M | 50.9 M | 50.9 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M |
Net Income |
-14 M | -12.7 M | -35.4 M | - | -36.1 M | -75.3 M | -53.3 M | - | -42.5 M | -58.9 M | -74.2 M | - | -58.8 M | -43.2 M | -64.3 M | -60.5 M | -46.1 M | -38.6 M | -37.6 M | -2.62 M | -37.6 M | -37.6 M | -31.1 M | -27.4 M | -29.6 M | -18.4 M | -25.8 M | -19.5 M | -15.1 M | -16.9 M | -14.2 M | -4.5 M | -11.5 M | -16.3 M | -22.8 M | -18.1 M | -14.6 M | 4.9 M | -15.2 M | -11.7 M | -8.73 M | -14.6 M | -10.1 M | -5.43 M | -8 M | -12.2 M | -4.51 M | -11.1 M | -9.7 M | -12.3 M | -6.05 M | -13.2 M | -14.5 M | -16.3 M | -13 M |
Revenue |
117 M | 109 M | 92.8 M | - | 86.7 M | 82.5 M | 68.8 M | - | 75.8 M | 65.5 M | 49.9 M | - | 41 M | 50 M | 19.1 M | 4.02 M | 6.1 M | 2.87 M | 4.82 M | 39.7 M | 1.78 M | 1.45 M | 5.89 M | 2.73 M | 1.45 M | 12.5 M | 3.98 M | 3.89 M | 8.76 M | 3.1 M | 9.44 M | 8.98 M | 7.76 M | 4.79 M | 4.82 M | 4.6 M | 11 M | 25.8 M | 6.83 M | 5.45 M | 3.24 M | 1.47 M | 3.46 M | 10.6 M | 2.39 M | 821 K | 3.55 M | 4.1 M | 5.76 M | 4.21 M | 12.2 M | 5.22 M | 5.25 M | 3.74 M | 5.44 M |
Cost of Revenue |
3.21 M | 1.7 M | 1.26 M | - | 1.1 M | 894 K | 931 K | - | 3.54 M | 246 K | 236 K | - | 591 K | 297 K | 5.92 M | - | 1.52 M | - | - | - | - | - | 1.4 M | - | - | - | - | - | 1.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
7.69 M | 8.76 M | -14.5 M | - | -11.9 M | -20.7 M | -28.4 M | - | -17.4 M | -34.7 M | -50 M | - | -44.6 M | -29.6 M | -51.4 M | - | -42.9 M | -38.5 M | -41 M | - | -35.1 M | -34.9 M | -29.3 M | - | -28.5 M | -18.3 M | -22.2 M | - | -13.3 M | -15.5 M | -10.7 M | - | -9.24 M | -12.1 M | -19 M | - | -13.2 M | 5.34 M | -14.4 M | - | -11.6 M | -11.6 M | -7.39 M | - | -6.92 M | -12.1 M | -5.32 M | - | -8.02 M | -10.2 M | -5 M | - | -12.8 M | -14.2 M | -11.5 M |
Interest Expense |
- | 24.7 M | 24.5 M | - | 27.3 M | 28.9 M | 27.4 M | - | 24.8 M | 24 M | 23.8 M | - | 14.1 M | 13.5 M | 12.9 M | - | 2.93 M | 2.92 M | 3.05 M | - | 3.04 M | 3.04 M | 2.73 M | - | 2.35 M | 2.2 M | 2.22 M | - | 2.14 M | 2.09 M | 2.1 M | - | 1.46 M | 1.42 M | 1.47 M | - | 1.24 M | 1.31 M | 1.32 M | - | 1.22 M | 1.22 M | 1.24 M | - | 1.19 M | 1.16 M | 1.18 M | - | 1.17 M | 1.16 M | 1.16 M | - | 1.16 M | 1.17 M | 288 K |
EBITDA |
- | - | -14.2 M | - | - | - | -28 M | - | -16.4 M | -34.7 M | -49.6 M | - | -44 M | -29.6 M | -51.2 M | - | -42.3 M | -38.1 M | -40.8 M | - | -34.6 M | -34.6 M | -29.2 M | - | -27.9 M | -17.9 M | -22 M | - | -12.8 M | -15.2 M | -10.5 M | - | -8.93 M | -12 M | -19 M | - | -13 M | 5.44 M | -14.4 M | - | -11.5 M | -11.5 M | -7.33 M | - | -6.68 M | -12 M | -5.22 M | - | -7.56 M | -9.85 M | -4.83 M | - | -12.2 M | -13.8 M | -11.5 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
65.1 M | 61.2 M | 59.4 M | - | 50.6 M | 51 M | 47.9 M | - | 36.9 M | 38 M | 34.3 M | - | 35 M | 26.3 M | 22.1 M | - | 17.2 M | 13.9 M | 15.9 M | - | 11.7 M | 8.66 M | 6.24 M | - | 7.92 M | 9.49 M | 7.61 M | - | 3.34 M | 2.83 M | 3.06 M | - | 2.76 M | 2.72 M | 3.21 M | - | 2.73 M | 3.53 M | 4.06 M | - | 1.81 M | 2.01 M | 1.59 M | - | 1.58 M | 1.43 M | 1.58 M | - | 1.59 M | 1.61 M | 1.7 M | - | 2.95 M | 3.54 M | 3.53 M |
All numbers in USD currency